Clinical trial · Observational
Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size
Percutaneous Tumor Ablation Versus Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size
NCT06829888CI-TRIAL-00086064CRYO-BO-2021completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim, of this study is to investigate recurrence rates in patients with T1 renal cell carcinoma (RCC) undergone partial nephrectomy (PN), radiofrequency ablation (RFA) or cryoablation (Cryo).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Cancer | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- localized (cN0 M0) renal mass (cT1) treated with partial nephrectomy
- description
- patients with clinically localized (cN0 M0) renal mass (cT1) treated with partial nephrectomy
- label
- localized (cN0 M0) renal mass (cT1) treated with percutaneus RFA
- description
- patients with clinically localized (cN0 M0) renal mass (cT1) treated with percutaneus RFA
- label
- localized (cN0 M0) renal mass (cT1) treated with percutaneous cryo
- description
- patients with clinically localized (cN0 M0) renal mass (cT1) treated with percutaneous cryo
Primary outcomes (1)
- measure
- 1. Disease recurrence of PN vs. RFA vs. Cryo after stratifying according to histological type and tumor size.
- timeFrame
- between January 2007 and July 2019
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 82 Years
Show eligibility criteria text
Inclusion Criteria: * Radiologic diagnosis (CT chest-abdomen or MRI abdomen with contrast medium) of renal neoplasm * Renal neoplasm of clinical stage T1a (≤4 cm) N0M0 * Age \>18 years * Informed consent * Absence of other neoplasm Exclusion Criteria: * Patients refuse partial nephrectomy and/or percutaneous renal CA and are candidates for active surveillance * Patients who are candidates for radical nephrectomy
References
Publications (0)
Data not yet available
No reference posted for this study.